VistaGen Therapeutics to Present at Two Investor Conferences in June
VistaGen Therapeutics (NASDAQ: VTGN) announced its participation in two upcoming investor conferences in June 2021. The Jefferies Virtual Healthcare Conference will take place on June 2 at 2:30 p.m. ET, while the William Blair 41st Annual Virtual Growth Stock Conference is scheduled for June 3 at 3:00 p.m. ET. Both conferences will feature webcasts available for attendees. VistaGen focuses on developing innovative medications for anxiety, depression, and other CNS disorders. For more details, visit www.vistagen.com.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing new generation medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system (“CNS”) disorders, today announced that it will present at the following investor conferences in June:
| Jefferies Virtual Healthcare Conference | |
| Date: | Wednesday, June 2nd at 2:30 p.m. ET |
| Webcast: | https://wsw.com/webcast/jeff174/vtgn/1876041 |
| Registration: | To attend the virtual conference, please contact your Jefferies representative. |
| William Blair 41st Annual Virtual Growth Stock Conference | |
| Date: | Thursday, June 3rd at 3:00 p.m. ET |
| Webcast: | https://wsw.com/webcast/blair58/vtgn/1959945 |
| Registration: | To attend the virtual conference, please contact your William Blair representative. |
For more information regarding these investor conferences, please visit the sponsor’s conference website.
About VistaGen
VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets. For more information, please visit www.vistagen.com and connect with VistaGen on Twitter, LinkedIn, and Facebook.
Company Contacts
Mark A. McPartland / Mark Flather
VistaGen Therapeutics, Inc.
Phone: +1 (650) 577-3600
Email: IR@vistagen.com
FAQ
What dates will VistaGen be presenting at investor conferences in June 2021?
How can I attend the Jefferies Virtual Healthcare Conference for VistaGen?
Where can I find the webcast for the William Blair Conference presentation by VistaGen?
What is the primary focus of VistaGen Therapeutics?
What is the stock symbol for VistaGen Therapeutics?
